SCHEMBL29909164

SCHEMBL29909164

Cc1nnc2nc(N(CC(F)F)c3cc(F)cc(C#CC4(C)CC4)c3)c3cc(F)ccc3n12

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTAFR P25105 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23577576 1.00 PTAFR (0.32) PTAFR
SCHEMBL24814734 0.93 PTAFR (0.30) PTAFR
SCHEMBL30048944 0.93 PTAFR (0.30) PTAFR
SCHEMBL29909521 0.87
SCHEMBL23576834 0.87
SCHEMBL24807746 0.86
SCHEMBL30146443 0.86
SCHEMBL24814753 0.86
SCHEMBL23576630 0.86 PTAFR (0.31) PTAFR
SCHEMBL29909230 0.86 PTAFR (0.31) PTAFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4445902-A2 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS Carna Biosciences, Inc. (JP) 2024-10-16 EP disclosed
EP-4081305-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS Carna Biosciences, Inc. (JP) 2022-11-02 EP disclosed